CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Naming therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02005016
NCT02005016N/ACompleted

Dosage and Predictors of Naming Treatment Response in Aphasia

VA Office of Research and Development·interventional·Posted Dec 9, 2013·Updated Nov 4, 2019

In Brief

A clinical study evaluating Naming therapy for Aphasia and Stroke. Completed, enrolled 46 participants across 1 site.

Detailed Summary

This study examines aphasia treatment response among Veterans and non-Veterans living with aphasia. It seeks to identify cognitive and neural factors which are predictive of positive response to treatment targeting naming impairments in aphasia. It also examines the dose-response relationship for naming treatment. More broadly, it seeks to determine who aphasia therapy works best for, and how much aphasia therapy is sufficient to achieve positive treatment response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphasia, Stroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 9, 2013
Enrollment StartOct 1, 2013
Primary CompletionSep 1, 2018
Study CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 12.6 years ago

Interventions

Naming therapybehavioral

Participants will receive behavioral therapy which is designed to stimulate semantic (meaning) representations which are required for successful naming (word production). Therapy will be administered for 4 weeks on an intensive schedule (5 days a week, approximately 4.5 hours per day).